Filler BMJ updates
Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosisBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39234.488356.DE (Published 05 July 2007) Cite this as: BMJ 2007;335:36
View Full Text
Research question Is once yearly intravenous zoledronic acid an effective treatment for postmenopausal osteoporosis?
Answer Yes. Yearly treatment prevents fractures and increases bone mineral density compared with a placebo.